Stratipath alternatives and competitors
The closest alternatives to Stratipath are Waiv, PreciseDx, Aiforia and DoMore Diagnostics.
Stratipath Breast assigns early stage invasive breast cancers to low or high risk groups from routine H&E slides, as a faster, cheaper alternative to gene expression tests for pathology laboratories and breast cancer teams in Europe.
10 alternatives to Stratipath
What each product does, with its price as the vendor publishes it.
-
W
Waiv sells AI tests that read routine H&E slides, for pathology laboratories and oncology teams in Europe, and biomarker services for drug developers.
Price: No published price
-
P
PreciseDx sells PreciseBreast, a test that predicts whether early breast cancer will come back, using AI to read the cell patterns on a routine stained slide.
Price: No published price
-
A
Aiforia sells cloud based deep learning image analysis that pathology laboratories use for cancer diagnostics and that researchers use for preclinical work.
Price: No published price
-
D
Histotype Px Colorectal predicts recurrence and survival in stage II and III colorectal cancer from standard H and E stained slides, placing patients in low, intermediate or high risk groups to inform whether adjuvant chemotherapy should follow surgery.
Price: No published price
-
P
Cleo Breast and Cleo Skin are AI tools for clinical pathology laboratories in Europe that detect and quantify cancer features in whole slide images.
Price: No published price
-
M
Mindpeak sells AI that scores cancer biomarkers on pathology slides, which laboratories use to quantify HER2, ER, PR, Ki-67 and PD-L1 on immunohistochemistry and H&E images.
Price: No published price
-
A
ArteraAI is the Los Altos, California company at artera.ai that builds multimodal AI cancer tests. It is unrelated to Artera of Santa Barbara (artera.io), which makes patient communication agents.
-
P
PathAI sells AISight, a cloud image management system that anatomic pathology laboratories use to manage cases, read slides on screen and run AI, along with its own algorithms and a menu of partner algorithms.
Price: No published price
-
D
Deep Bio builds deep learning algorithms for cancer pathology, led by prostate.
Price: No pricing published; sold through third party platforms, unit of charge unstated
-
V
Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.
Price: No published price
Stratipath alternatives, answered
What are the best alternatives to Stratipath?
The closest alternatives to Stratipath are Waiv, PreciseDx, Aiforia, DoMore Diagnostics and Primaa. Waiv sells AI tests that read routine H&E slides, for pathology laboratories and oncology teams in Europe, and biomarker services for drug developers. PreciseDx sells PreciseBreast, a test that predicts whether early breast cancer will come back, using AI to read the cell patterns on a routine stained slide. Aiforia sells cloud based deep learning image analysis that pathology laboratories use for cancer diagnostics and that researchers use for preclinical work.
Who are Stratipath's competitors?
Stratipath's competitors in the Digital Pathology AI category include Waiv, PreciseDx, Aiforia, DoMore Diagnostics, Primaa and Mindpeak.